MF
IMGN

Manchester Financial’s Immunogen Inc IMGN Stock Holding History

Manchester Financial’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-900
Closed -$7K – 710
2021
Q1 		$7K Hold
900
– – ﹤0.01% 501
2020
Q4 		$6K Hold
900
– – ﹤0.01% 447
2020
Q3 		$3K Hold
900
– – ﹤0.01% 472
2020
Q2 		$4K Hold
900
– – ﹤0.01% 420
2020
Q1 		$3K Hold
900
– – ﹤0.01% 414
2019
Q4 		$5K Buy
+900
New +$3.05K ﹤0.01% 435
2019
Q3 		– Sell
-900
Closed -$2K – 471
2019
Q2 		$2K Buy
+900
New +$2.13K ﹤0.01% 453

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Manchester Financial's IMGN Position: Q2 2021 in Review

Manchester Financial sold out of Immunogen Inc (IMGN) in Q2 2021, closing a stake of 900 shares — an estimated $7K sold.

Manchester Financial first reported a position in IMGN in Q2 2019 and held it in 7 quarters. The position peaked at $7K in Q1 2021. 214 funds tracked by Wall St. Rank hold IMGN as of Q2 2021.

  • Manchester Financial reported no remaining Immunogen Inc position as of Q2 2021 after selling out during the quarter.
  • Manchester Financial sold 900 Immunogen Inc shares in Q2 2021, an estimated $7K.
  • Manchester Financial first reported a position in Immunogen Inc in Q2 2019 and held it in 7 quarters.
  • Manchester Financial's Immunogen Inc position peaked at $7K in Q1 2021.
  • 214 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.